Witnessing the stock’s movement on the chart, on Wednesday, Ernexa Therapeutics Inc (NASDAQ: ERNA) set off with pace as it heaved 40.80% to $1.76, before settling in for the price of $1.25 at the close. Taking a more long-term approach, ERNA posted a 52-week range of $1.09-$18.75.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 35.26%. Meanwhile, its Annual Earning per share during the time was 35.26%. This publicly-traded company’s shares outstanding now amounts to $7.48 million, simultaneously with a float of $3.08 million. The organization now has a market capitalization sitting at $13.50 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2858, while the 200-day Moving Average is $2.8400.
Ernexa Therapeutics Inc (ERNA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Ernexa Therapeutics Inc’s current insider ownership accounts for 59.82%, in contrast to 0.65% institutional ownership. According to the most recent insider trade that took place on Jun 09 ’25, this organization’s 10% Owner bought 21,241,163 shares at the rate of 0.10, making the entire transaction reach 2,221,826 in total value, affecting insider ownership by 41,659,743. Preceding that transaction, on Apr 02 ’25, Company’s 10% Owner bought 3,768,397 for 0.10, making the whole transaction’s value amount to 394,174. This particular insider is now the holder of 20,401,602 in total.
Ernexa Therapeutics Inc (NASDAQ: ERNA) Trading Performance Indicators
Let’s observe the current performance indicators for Ernexa Therapeutics Inc (ERNA). It’s Quick Ratio in the last reported quarter now stands at 1.81. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 27.55.
In the same vein, ERNA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -78.36.
Technical Analysis of Ernexa Therapeutics Inc (ERNA)
Going through the that latest performance of [Ernexa Therapeutics Inc, ERNA]. Its last 5-days volume of 43.05 million indicated improvement to the volume of 1.3 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 44.29% While, its Average True Range was 78.97.
Raw Stochastic average of Ernexa Therapeutics Inc (ERNA) in the period of the previous 100 days is set at 35.08%, which indicates a major fall in contrast to 37.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1560 that was higher than 0.1548 volatility it exhibited in the past 100-days period.
